159
Views
4
CrossRef citations to date
0
Altmetric
Articles

Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma

, &
Pages 417-425 | Received 28 Mar 2010, Accepted 28 Jun 2010, Published online: 21 Sep 2010

References

  • Ach T, Thiemeyer D, Hoeh AE, Schaal KB, Dithmar S. 2010. Intravitreal bevacizumab for retinal capillary haemangioma: Longterm results. Acta Ophthalmol. 88:e137–e138.
  • Anthony FW, Evans PW, Wheeler T, Wood PJ. 1997. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem. 34:276–280.
  • Barnés CM, Christison-Lagay EA, Folkman J. 2007. The placenta theory and the origin of infantile hemangioma. Lymphat Res Biol. 5:245–255.
  • Carmeliet P. 2005. Angiogenesis in life, disease and medicine. Nature. 438:932–936.
  • Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, Jia X, Kerbel RS. 2004. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res. 2:315–326.
  • Folkman J. 2007. Is angiogenesis an organizing principle in biology and medicine?. J Pediatr Surg. 42:1–11.
  • Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon MC, Nopper AJ, Siegel DH, Mathes EW, Goddard DS, Bischoff J, North PE, Esterly NB. 2005. Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol. 22:383–406 April 7-9,2005, Bethesda, Maryland.
  • Frischer JS, Huang J, Serur A, Kadenhe A, Yamashiro DJ, Kandel JJ. 2004. Biomolecular markers and involution of hemangiomas. J Pediatr Surg. 39:400–404.
  • Fuh G, Li B, Crowley C, Cunningham B, Wells JA. 1998. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem. 273:197–204.
  • Ilhan N, Ilhan N, Deveci F. 2004. Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types. Clin Biochem. 37:840–845.
  • Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR. 2008. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med. 14:1236–1246.
  • Kendall RL, Wang G, Thomas KA. 1996. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun. 226:324–328.
  • Korzeniewska M, Kołomecki K, Stepień H, Naze M, Stepień T, Kuzdak K. 2005. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors]. Endokrynol Pol. 56:39–44 Polish.
  • Li Zhang, Lin X, Wang W, Zhuang X, Dong J, Qi Z, Hu Q. 2005. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation. Plast Reconstr Surg. 116:200–204.
  • Marler JJ, Fishman SJ, Kilroy SM. 2005. Increased expression of urinary matrix metalloproteinases parallels extent and activity of vascular anomalies. Pediatrics. 116:38–45.
  • Przewratil P, Sitkiewicz A, Andrzejewska E. 2010. Local serum levels of vascular endothelial growth factor in infantile hemangioma: Intriguing mechanism of endothelial growth. Cytokine. 49:141–147.
  • Roberts JM, Rajakumar A. 2009. Preeclampsia and soluble fms-like tyrosine kinase 1. J Clin Endocrinol Metab. 94:2252–2254.
  • Shibuya M. 2006. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol. 39:469–478.
  • Shibuya M. 2006. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): A dual regulator for angiogenesis. Angiogenesis. 9:225–230.
  • Soker S, Svahn CM, Neufeld G. 1993. Vascular endothelial growth factor is inactivated by binding to α2-macroglobulin and the binding is inhibited by heparin. J Biol Chem. 268:7685–7691.
  • Swidzińska E, Ossolińska M, Naumnik W, Izycki T, Kucejko W, Chyczewska E. 2004. [Circulating VEGF and its soluble receptor sVEGFR-1 in patients with lung cancer]. Pneumonol Alergol Pol. 72:389–394 Polish.
  • Takahashi H, Shibuya M. 2005. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 109:227–241.
  • Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. 1994. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 269:88–95.
  • Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature. 407:242–248.
  • Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J. 2004. Endothelial progenitor cells in infantile hemangioma. Blood. 103:1373–1375.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.